Pfizer Inc. et al v. Biocon Limited et al
| Pfizer Inc. and PF PRISM IMB B.V. |
| Biocon Limited, Biocon Pharma Limited and Biocon Pharma, Inc. |
| 1:2026cv00441 |
| April 16, 2026 |
| U.S. District Court for the District of Delaware |
| Jennifer L Hall |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 24, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 STIPULATION TO EXTEND TIME for Defendants Biocon Limited, Biocon Pharma Limited, and Biocon Pharma, Inc. to respond to the Complaint (D.I. 1) to June 22, 2026 - filed by PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) |
| Filing 9 WAIVER OF SERVICE returned executed by Pfizer Inc., PF PRISM IMB B.V.: For Biocon Limited waiver sent on 4/22/2026, answer due 6/22/2026. (Dellinger, Megan) |
SO ORDERED, re #10 Stipulation and Order to Extend Time for Defendants to Respond to the Complaint to June 22, 2026. (*Reset Answer Deadlines: Biocon Pharma Limited answer due 6/22/2026; Biocon Pharma, Inc. answer due 6/22/2026; Biocon Limited answer due 6/22/2026). Ordered by Judge Jennifer L. Hall on 4/24/2026. (ceg)
|
| Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:26-cv-00439-UNA, 1:26-cv-00440-UNA, 1:26-cv-00441-UNA (alb) |
| Filing 8 SUMMONS Returned Executed by Pfizer Inc., PF PRISM IMB B.V..Biocon Pharma, Inc. served on 4/20/2026, answer due 5/11/2026. (Dellinger, Megan) |
| Filing 7 AFFIDAVIT of Service for Summons, Complaint and related papers served on Biocon Pharma Limited on April 20, 2026, filed by PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) |
| Filing 6 Summons Issued as to Biocon Limited on 4/17/2026; Biocon Pharma Limited on 4/17/2026; Biocon Pharma, Inc. on 4/17/2026. (Attachments: #1 Summons Issued, #2 Summons Issued)(scs) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for PF PRISM IMB B.V. filed by PF PRISM IMB B.V., Pfizer Inc.. (scs) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,035,074 B2. (scs) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: March 13, 2026. Date of Expiration of Patent: January 14, 2036.Thirty Month Stay Deadline: 7/14/2029. (scs) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) |
| Filing 1 COMPLAINT against Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc. (Filing fee $ 405, receipt number ADEDC-4949761) - filed by Pfizer Inc., PF PRISM IMB B.V.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(scs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
